Galapagos NV
GLPG
#5080
Rank
S$2.40 B
Marketcap
S$35.81
Share price
0.00%
Change (1 day)
-1.55%
Change (1 year)

Galapagos NV (GLPG) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : S$0.17 Billion

According to Galapagos NV's latest financial reports the company's total liabilities are S$0.17 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Galapagos NV - Total liabilities on balance sheet (from 2008 to 2026)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$1.75 B-23.16%
2023-12-31S$2.28 B-28.2%
2022-12-31S$3.17 B-18.65%
2021-12-31S$3.90 B-21.27%
2020-12-31S$4.95 B2.83%
2019-12-31S$4.82 B1269.83%
2018-12-31S$0.35 B-20.03%
2017-12-31S$0.44 B-10.93%
2016-12-31S$0.49 B312.23%
2015-12-31S$0.11 B15.97%
2014-12-31S$0.10 B-50.86%
2013-12-31S$0.21 B11.27%
2012-12-31S$0.18 B163.41%
2011-12-31S$71.77 M-7.83%
2010-12-31S$77.87 M11.16%
2009-12-31S$70.06 M1.57%
2008-12-31S$68.97 M-34.47%
2007-12-31S$0.10 B-10.46%
2006-12-31S$0.11 B191.8%
2005-12-31S$40.28 M247.04%
2004-12-31S$11.6 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
S$154.57 B 86,768.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$74.54 B 41,791.69%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$184.74 B 103,725.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$82.02 B 45,995.08%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$106.85 B 59,952.39%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$86.03 B 48,252.36%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$77.71 B 43,575.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
S$0.15 B-15.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$41.07 B 22,982.23%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel